Maurizio Chioccioli, PhD
Cards
About
Titles
Assistant Professor of Comparative Medicine and of Genetics
Biography
Mau is an Assistant Professor in Genetics and Comparative Medicine at Yale School of Medicine. His research focus is to understand the molecular and cellular mechanisms that govern tissue regeneration and repair in the lung, and how these pathways are hijacked in disease. His experience and expertise span multiple areas from biophysics and live-imaging microscopy to molecular biology, genetics, and human respiratory diseases. Mau is from Arezzo, Tuscany. He obtained his undergraduate degree at the University of Florence in Tuscany, before going on to obtain his PhD from the Institute for Molecular Bioscience at the University of Queensland in Australia. He then performed his postdoctoral studies at the Cavendish Laboratory, Physics of Medicine Institute at Cambridge University where he worked on the biophysical basis of dynamic ciliary beating in respiratory diseases such as cystic fibrosis and primary ciliary dyskinesia. He was recruited into the lab of Naftali Kaminski at Yale School of Medicine in 2018 where he focused primarily on establishing new techniques and approaches to investigate lung remodeling and repair. He was appointed Assistant Professor in Genetics and Comparative Medicine in September 2023.
Appointments
Comparative Medicine
Assistant ProfessorFully JointGenetics
Assistant ProfessorFully JointPulmonary, Critical Care & Sleep Medicine
Assistant ProfessorSecondary
Other Departments & Organizations
Education & Training
- PhD
- University of Queensland, Molecular Biosciences
- MSc
- Universita Degli Studi Di Firenze, Molecular Biology (2007)
- BSc
- Universita Degli Studi Di Firenze, Biology (2004)
Research
Overview
Medical Subject Headings (MeSH)
Academic Achievements and Community Involvement
Links & Media
News
- July 09, 2024
Meet Maurizio Chioccioli and his research on lung injury repair
- February 21, 2024Source: YaleNews
Stem Cells ‘Migrate’ to Repair Damaged Lung Cells, Study Shows
- October 28, 2022
Newly Designed Molecule Is Promising Potential Therapy for Deadly Lung Condition
- April 18, 2019Source: Cystic Fibrosis News Today
New Test Could Lead to Effectively Customizing Treatments for CF Patients, Study Contends